Home › Funds › PRELUDE CAPITAL MANAGEMENT, LLC › ETON
PRELUDE CAPITAL MANAGEMENT, LLC position in ETON
ETON PHARMACEUTICALS INC · Health Care
PRELUDE CAPITAL MANAGEMENT, LLC reported holding 97,576 shares of ETON (ETON PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 0.41% of its reported portfolio and ranking #35 among its reported holdings. PRELUDE CAPITAL MANAGEMENT, LLC has disclosed ETON holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How PRELUDE CAPITAL MANAGEMENT, LLC's ETON position evolved
PRELUDE CAPITAL MANAGEMENT, LLC first disclosed a stake in ETON in Q4 2024 at 24,242 shares (US$323K). The position peaked in Q3 2026 at 97,576 shares, worth US$5.0M. Across 8 filings, PRELUDE CAPITAL MANAGEMENT, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 97,576 shares valued at US$5.0M — a reduction of -39,996 shares quarter over quarter.. Notable position changes include a 599% increase in Q1 2025 (shares rose 10% over the following quarter), a 74% trim in Q2 2025 (shares rose 52% over the following quarter), a 317% increase in Q1 2026 (shares rose 47% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 24.24K | $322.90K | New |
| Q1 2025 | 169.44K | $2.20M | Add |
| Q2 2025 | 43.60K | $621.30K | Reduce |
| Q3 2025 | 41.87K | $909.90K | Reduce |
| Q4 2025 | 45.33K | $766.45K | Add |
| Q1 2026 | 188.80K | $4.66M | Add |
| Q2 2026 | 137.57K | $4.98M | Reduce |
| Q3 2026 | 97.58K | $5.02M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC) is a Health Care company. 69 other funds we track also report a position in ETON — the largest reported positions include EcoR1 Capital, LLC (US$127.2M), Opaleye Management Inc. (US$103.5M), Nantahala Capital Management, LLC (US$45.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- EcoR1 Capital, LLC 2.47M sh · $127.23M · Q3 2026
- Opaleye Management Inc. 2.86M sh · $103.53M · Q2 2026
- Nantahala Capital Management, LLC 875.51K sh · $45.08M · Q3 2026
- National Philanthropic Trust 492.11K sh · $25.34M · Q3 2026
- Westside Investment Management, Inc. 401.38K sh · $20.67M · Q3 2026
- Pillsbury Lake Capital LLC 288.27K sh · $14.84M · Q3 2026
- Lumbard & Kellner, LLC 173.26K sh · $8.92M · Q3 2026
- Panoramic Capital, LLC 208.19K sh · $7.54M · Q2 2026
- Informed Momentum Co LLC 139.21K sh · $7.17M · Q3 2026
- CANNELL CAPITAL LLC 170.75K sh · $6.18M · Q2 2026
- Prospect Capital Advisors, LLC 157.20K sh · $5.69M · Q2 2026
- Bridge City Capital, LLC 86.77K sh · $4.47M · Q3 2026
More on PRELUDE CAPITAL MANAGEMENT, LLC
FAQ
How long has PRELUDE CAPITAL MANAGEMENT, LLC held ETON?
PRELUDE CAPITAL MANAGEMENT, LLC has disclosed ETON holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is PRELUDE CAPITAL MANAGEMENT, LLC's current position in ETON?
As of Q3 2026, PRELUDE CAPITAL MANAGEMENT, LLC holds 97.58K shares of ETON (ETON PHARMACEUTICALS INC), valued at $5.02M, representing 0.41% of its reported portfolio and ranking #35.
Has PRELUDE CAPITAL MANAGEMENT, LLC been buying or selling ETON?
In the latest 13F filing (Q3 2026), PRELUDE CAPITAL MANAGEMENT, LLC reduced its position in ETON. The position peaked in Q3 2026 at 97.58K shares.
Which other funds hold ETON?
Other major institutional holders of ETON include EcoR1 Capital, LLC, Opaleye Management Inc., Nantahala Capital Management, LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.